Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC

ClinicalTrials.gov ID: NCT04265534

Public ClinicalTrials.gov record NCT04265534. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 3:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2, randomized, multicenter, double-blind study of the glutaminase inhibitor telaglenastat with standard-of-care pembrolizumab and chemotherapy versus placebo with standard-of-care pembrolizumab and chemotherapy for first line treatment of metastatic disease in patients with KEAP1/NRF2-mutated, stage IV, nonsquamous, non-small cell lung cancer (NSCLC). The study primary endpoints are PFS per RECIST v. 1.1 and safety. KEAP1/NRF2 mutation status (for eligibility) and STK11/LKB1 status (for stratification) will be determined by next generation sequencing. A commercial liquid biopsy (circulating tumor DNA) NGS test will be provided to study participants free of charge.

Study identification

NCT ID
NCT04265534
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Calithera Biosciences, Inc
Industry
Enrollment
40 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 24, 2020 (Actual)
Primary completion
Nov 5, 2021 (Actual)
Completion
Feb 9, 2022 (Actual)
Last update posted
Sep 21, 2022

2020 – 2022

United States locations

U.S. sites
102
U.S. states
34
U.S. cities
89
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294 —
University of South Alabama - Mitchell Cancer Center Mobile Alabama 36604 —
Yuma Regional Medical Center Yuma Arizona 85364 —
Compassionate Cancer Care Fountain Valley California 92708 —
St. Joseph Heritage Healthcare Fullerton California 92835 —
Loma Linda University Medical Center Loma Linda California 92350 —
University of Southern California (USC) Los Angeles California 90033 —
Cedars-Sinai Medical Center Los Angeles California 90048 —
UCLA Los Angeles California 90095 —
University of California Irvine, Chao Family Comprehensive Cancer Center Orange California 92868 —
St. Joseph Heritage Healthcare - Santa Rosa Santa Rosa California 95403 —
Johns Hopkins Sibley Memorial Hospital Washington D.C. District of Columbia 20016 —
Sibley Memorial Hospital Washington D.C. District of Columbia 20016 —
Boca Raton Regional Hospital Lynn Cancer Institute Boca Raton Florida 33486 —
Holy Cross Hospital - Bines Cancer Center Fort Lauderdale Florida 33308 —
Florida Cancer Specialist - South (SCRI) Fort Myers Florida 33901 —
Memorial Cancer Institute at Memorial Hospital West Hollywood Florida 33021 —
University of Miami Sylvester Comprehensive Cancer Center Miami Florida 33136 —
Ocala Oncology Center Ocala Florida 34474 —
Florida Cancer Specialist - North (SCRI) St. Petersburg Florida 33705 —
Florida Cancer Specialist - Panhandle (SCRI) Tallahassee Florida 32308 —
Moffitt Cancer Center Tampa Florida 33612 —
Florida Cancer Specialist - East (SCRI) West Palm Beach Florida 33401 —
University Cancer and Blood Center Athens Georgia 30607 —
Piedmont Cancer Institute Atlanta Georgia 30318 —
Emory University Hospital Atlanta Georgia 30322 —
Northwest Georgia Oncology Marietta Georgia 30060 —
Hawaii Cancer Care Honolulu Hawaii 96813 —
Oncology of Northshore Rolling Meadows Illinois 60008 —
Orchard Healthcare Research Inc. Skokie Illinois 60077 —
Fort Wayne Medical Oncology and Hematology Fort Wayne Indiana 46804 —
Beacon Health South Bend Indiana 46601 —
University of Kansas Medical Center (KUMC) Westwood Kansas 66205 —
Pontchartrain Cancer Center Covington Louisiana 70443 —
Johns Hopkins Bayview Memorial Hospital Baltimore Maryland 21224 —
Center for Cancer and Blood Disorders Bethesda Maryland 20817 —
Maryland Oncology Hematology - USOR Columbia Maryland 21044 —
Frederick Health - James M. Stockman Cancer Institute Frederick Maryland 21702 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Henry Ford Cancer Institute Detroit Michigan 48202 —
Bronson Methodist Hospital (West Michigan Cancer Center) Kalamazoo Michigan 49001 —
St. Joseph Mercy Hospital Cancer Care Center Ypsilanti Michigan 48197 —
Minnesota Oncology Hematology, P.A. Coon Rapids Minnesota 55433 —
Minnesota Oncology Hematology, P.A. Edina Minnesota 55435 —
Minnesota Oncology Hematology, P.A. Maplewood Minnesota 55109 —
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404 —
Minnesota Oncology Hematology, P.A. Saint Paul Minnesota 55102 —
Minnesota Oncology Hematology, P.A. Woodbury Minnesota 55125 —
Central Care Cancer Center Bolivar Missouri 65613 —
Washington University St Louis Missouri 63110 —
Nebraska Methodist Hospital Omaha Nebraska 68114 —
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03766 —
New Jersey Cancer Care and Blood Disorders (NJCCBD) Belleville New Jersey 07109 —
Summit Medical Group Berkeley Heights New Jersey 07932 —
The Valley Hospital - Luckow Pavilion Paramus New Jersey 07652 —
University of New Mexico Comprehensive Cancer Center Albuquerque New Mexico 87131 —
New York Oncology Hematology, P.C. (400 Patoon Creek Blvd.) Albany New York 12206 —
New York Oncology Hematology, P.C. (43 New Scotland Ave.) Albany New York 12208 —
Roswell Park Comprehensive Cancer Center Buffalo New York 14263 —
New York Oncology Hematology, P.C. Clifton Park New York 12065 —
Pelmutter Cancer Center at Winthrop Mineola New York 11501 —
New York University Langone (NYU) New York New York 10016 —
Columbia University Medical Center New York New York 10032 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Weill Cornell Medical College - New York Presbyterian Hospital New York New York 10065 —
Cone Health at Alamance Regional Burlington North Carolina 27215 —
Cone Health Cancer Center Greensboro North Carolina 27403 —
Aultman Hospital Canton Ohio 44710 —
TriHealth Cancer Institute Cincinnati Ohio 45220 —
Ohio State University, James Cancer Hospital and Solove Research Institute Columbus Ohio 43210 —
Ohio Health Columbus Ohio 43214 —
Toledo Clinic Cancer Center Toledo Ohio 43623 —
Oklahoma Cancer Specialists and Research Institute (OCSRI) Tulsa Oklahoma 74146 —
Providence Portland Medical Center Portland Oregon 92713 —
Oregon Health & Science University (OHSU) Knight Cancer Institute Portland Oregon 97239 —
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 —
Pennsylvania State University Milton S. Hershey Medical Center State College Pennsylvania 16801 —
Sanford Health Sioux Falls South Dakota 57104 —
Tennessee Oncology - Chattanooga (SCRI) Chattanooga Tennessee 37404 —
Tennessee Oncology - Nashville (SCRI) Nashville Tennessee 37203 —
Texas Oncology - Austin Midtown Austin Texas 78705 —
Texas Oncology - Austin Central Austin Texas 78731 —
Texas Oncology - South Austin Austin Texas 78745 —
Texas Oncology Beaumont - USOR Beaumont Texas 77701 —
Texas Oncology - Denison Denison Texas 75020 —
Texas Oncology - Fort Worth Cancer Center Fort Worth Texas 76104 —
Oncology Consultants Houston Texas 770390 —
Oncology and Hematology of South Texas Laredo Texas 78041 —
Utah Cancer Specialist Salt Lake City Utah 84106 —
University of Utah - Huntsman Cancer Institute Salt Lake City Utah 84112 —
Oncology and Hematology Associates of Southwest Virginia Blacksburg Virginia 24060 —
Virginia Cancer Specialists Fairfax Virginia 22031 —
Oncology and Hematology Associates of Southwest Virginia Low Moor Virginia 24457 —
Virginia Commonwealth University (VCU) Massey Cancer Center Richmond Virginia 23298 —
Oncology and Hematology Associates of Southwest Virginia Roanoke Virginia 24014 —
Oncology and Hematology Associates of Southwest Virginia Salem Virginia 24153 —
Oncology and Hematology Associates of Southwest Virginia Wytheville Virginia 24382 —
University of Washington Seattle Cancer Care Alliance (SCCA) Seattle Washington 98109 —
Northwest Medical Specialities Tacoma Washington 98405 —
University of Wisconsin Carbone Cancer Center Madison Wisconsin 53705 —
Froedtert Hospital and the Medical College of Wisconsin (MCW) Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04265534, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 21, 2022 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04265534 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →